SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001714899-23-000050
Filing Date
2023-02-27
Accepted
2023-02-27 16:08:07
Documents
5
Effectiveness Date
2023-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82023.htm S-8 80524
2 EX-FILING FEES s-8ex1071filingfeetable2023.htm EX-FILING FEES 19201
3 EX-5.1 s-8exhibit512023.htm EX-5.1 8341
4 EX-23.1 s-8exhibit2312023.htm EX-23.1 2532
5 image_1.jpg GRAPHIC 365942
  Complete submission text file 0001714899-23-000050.txt   605909
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270040 | Film No.: 23674828
SIC: 2836 Biological Products, (No Diagnostic Substances)